- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 23 - The Affordable Care Act and Healthcare Reform
During this segment, David Calabrese, RPh, MHP, Kenneth L. Schaecher, MD, FACP, CPC, and Yehuda Handelsman, MD, FACP, FACE, FNLA, discuss the advantages and disadvantages of transitioning into a new model of patient care as set forth by healthcare reform and the Affordable Care Act.
Because he believes that this transition allows healthcare professionals the opportunity to take advantage of new information technology, increase coordination and communication with colleagues, and focus on prevention and wellness programs that are vital to the management of cardiometabolic conditions, Mr Calabrese explains that healthcare professionals need to embrace the goals set forth by healthcare reform.
Despite its advantages, as discussed by Mr Calabrese, Dr Schaecher and Dr Handelsman explain that certain factors may continue to affect a clinician’s treatment recommendations and impede the opportunity to deliver optimal care to patients.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
